Pulse Biosciences Inc Market cap
What is the Market cap of Pulse Biosciences Inc?
The Market cap of Pulse Biosciences Inc is $107.59M
What is the definition of Market cap?
Market capitalization is the market value at a point in time of the shares outstanding of a publicly traded company, being equal to the share price at that point of time times the number of shares outstanding.
= outstanding shares * previous day’s close
As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.
Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.
The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.
Market cap of companies in the Health Care sector on NASDAQ compared to Pulse Biosciences Inc
What does Pulse Biosciences Inc do?
pulse biosciences, inc. is a clinical stage electroceutical, an electrical energy based therapeutic, company pursuing commercial applications of its proprietary nano-pulse stimulation (nps) technology. nps is a non-thermal, drug-free energy-based technology that can stimulate unique behaviors in cells by applying ultra-short nanosecond (billionths of a second) electrical pulses that affect the cell membrane and intracellular structures. these cell effects influence cell regulation functions and can lead to unique immune system responses. pulse biosciences is investigating a variety of applications for its nps technology that exploits its unique biologic effect, including immuno-oncology and dermatology. pulse biosciences, inc. (plse, nasdaq) corporate headquarters is located in hayward, ca. ~ our mission ~ to build a viable company that designs, produces, and commercializes nano-pulse technology to improve and extend the lives of patients to solve the needs of patients, physicians, and
Companies with market cap similar to Pulse Biosciences Inc
- Nova Royalty has Market cap of $107.36M
- Fronsac Real Estate Investment Trust has Market cap of $107.48M
- Creades AB has Market cap of $107.54M
- Volpara Health Technologies has Market cap of $107.55M
- Baring Emerging Europe Plc has Market cap of $107.57M
- Intergroup has Market cap of $107.59M
- Pulse Biosciences Inc has Market cap of $107.59M
- Mind Gym plc has Market cap of $107.61M
- HKE has Market cap of $107.62M
- Pioneer Floating Rate Fund Inc has Market cap of $107.62M
- Bardoc Gold has Market cap of $107.64M
- Alio Gold has Market cap of $107.66M
- Southeast Asia Properties & Finance has Market cap of $107.69M